In the BioHarmony Drug Report Database
Metaxalone, Skelaxin (metaxalone) is a small molecule pharmaceutical. Metaxalone was first approved as Metaxalone on 1982-01-01. It is used to treat muscle cramp, muscle rigidity, muscle spasticity, myositis, and pain amongst others in the USA. Skelaxin’s patents are valid until 2026-02-06 (FDA).
Image (chem structure or protein)